Thus CD40 targeted therapy may have a dual beneficial effect comprising direct tumor cell signaling, leading to growth arrest or even apoptosis, and DC-dependent stimulatory activity on antitumor T-cell immunity. The gene discussed is CD40; the disease is neoplasm.